Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator
MedTech Innovator, the world’s largest accelerator of medical technology companies announced today that 24 medtech […]
RQM+ Acquires Libra Medical
RQM+, the world’s leading MedTech service provider, has announced the acquisition of Libra Medical, a […]
RQM+ Appoints Steven Pilewski as Lab Services Chief Operating Officer
RQM+, the world’s leading MedTech service provider, has announced the appointment of Steven Pilewski as […]
Lena Wagner & Simone Marquardt, Raumedic, on Components for the Pharmaceutical and MedTech Industries
In this video, Lena Wagner and Simone Marquardt from Raumedic discuss the components that the […]
mdgroup Launches Third Fully Compliant Medical Distribution Centre in Amsterdam
mdgroup, a leading global MedTech and patient health services company pioneering a patient-first approach to […]
ClariMed Launches Integrated Medical Device Services Partner
ClariMed has announced the launch of the first MedTech services partner to take an integrated, […]
OxSonics Announces First-in-human Clinical Data Shows SonoTran(R) is Safe and Well-tolerated
OxSonics Therapeutics, a clinical-stage medtech company focused on transforming cancer treatment through SonoTran, its proprietary […]
OstomyCure Announces Completion of Patient Recruitment Milestone in Pivotal TIES Clinical Trial
OstomyCure, a clinical-stage medtech company developing revolutionary technologies to transform the lives of people with […]
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more